Skip to main content
. 2010 Oct 7;15(10):1113–1121. doi: 10.1634/theoncologist.2010-0106

Table 2.

Summary of trials investigating incidence of HBV reactivation after rituximab treatment

graphic file with name onc01010-0675-t02.jpg

Abbreviations: (−), negative; (+), positive; anti-HBc, antibody to hepatitis B core antigen; anti-HBs, antibody to hepatitis B surface antigen; HBsAb, hepatitis B surface antibody; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; HCV, hepatitis C virus; NR, not reported.